Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups

Top Framing Differences

• Left: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.
• Center: Sofinnova Partners, a Paris-based life sciences investor, has closed its Sofinnova MD Start IV fund at €82 million. The firm said the fund was oversubscribed and will build on a strategy dating back to 2008 that has created around a dozen companies. “Sofinnova MD Start is one of the few strategies in Europe focused on […] The post Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups appeared first on EU-Startups .
• Right: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.